Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 3, Number 6, December 2011, pages 279-284


Short-Term Effects of High-Frequency Chest Compression and Positive Expiratory Pressure in Patients With Cystic Fibrosis

Figure

Figure 1.
Figure 1. Mean and individual values of sputum expectoration after PEP and HFCC in 34 CF patients.

Tables

Table 1. Demographics of Enrolled Participants
 
Demographics and baseline characteristicsvalue
BMI: body mass index; SpO2: transcutaneous pulsed arterial oxygen saturation; FEV1: forced expiratory volume in 1 second. Data are presented as mean ± SD or ratio as appropriate.
Age (year)26 ± 6.5
Gender (M / F)14 / 20
BMI (kg/m2)19.72 ± 6.35
SpO2 (%)97.7 ± 1.4
FEV1 (% pred)67 ± 17

 

Table 2. Lung Function Values: Before (Pre) and After (Post) PEP and HFCC Treatments
 
DeviceFEV1FEF25-75 (%)FVC (%)SpO2 (%)
(% predicted)
prepostprepostprepostprepost
FEV1: forced expiratory volume in 1 second; FEF25-75: forced expiratory flow 25 - 75%; FVC, forced vital capacity. *P < 0.001. No statistically significant difference was found in spirometric values before and after both treatments. A statistically significant decrease in SpO2 values was found after PEP treatment.
HFCC67 ± 1766 ± 1734 ± 2133 ± 2188 ± 1787 ± 1697 ± 1.697 ± 1.2
PEP67 ± 1667 ± 1634 ± 2034 ± 1988 ± 1587 ± 1598 ± 1.097 ± 1.2*

 

Table 3. Borg Dyspnea Scale Before (Pre) and After (Post) PEP and HFCC Treatments
 
PrePostP value
Both treatments induced a statistically significant increase in Borg scale for dyspnea, without differences between them.
HFCC0.7 ± 0.91.5 ± 1.7< 0.01
PEP0.9 ± 1.21.6 ± 1.6< 0.001